Home / LYST Knockout Cell Lines

LYST Knockout Cell Lines

Gene: LYST

Official Full Name: lysosomal trafficking regulatorprovided by HGNC

Gene Summary: This gene encodes a protein that regulates intracellular protein trafficking in endosomes, and may be involved in pigmentation. Mutations in this gene are associated with Chediak-Higashi syndrome, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants, though the full-length nature of some of these variants has not been determined. [provided by RefSeq, Apr 2013]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO38547 LYST Knockout cell line (HeLa) Human LYST 1:3~1:6 Negative Online Inquiry
KO38548 LYST Knockout cell line (HCT 116) Human LYST 1:2~1:4 Negative Online Inquiry
KO38549 LYST Knockout cell line (HEK293) Human LYST 1:3~1:6 Negative Online Inquiry
KO38550 LYST Knockout cell line (A549) Human LYST 1:3~1:4 Negative Online Inquiry

Background

LYST Gene Knockout Cell Lines represent a revolutionary tool set in the field of genetic research, specifically designed to facilitate the study of lysosomal trafficking and related cellular processes. These cell lines are engineered to have a targeted deletion of the LYST (lysosomal trafficking regulator) gene, which is pivotal for lysosomal biogenesis and function. By disrupting this gene, researchers can investigate the mechanistic pathways involved in lysosomal storage disorders and other related diseases, enabling deeper insights into cellular homeostasis and pathology.

The primary function of the LYST knockout cell lines lies in their ability to mimic disease states that are characterized by dysfunctional lysosomal activity. Mechanistically, the loss of LYST leads to alterations in the trafficking and degradation of lysosomal substrates, presenting a unique opportunity to study the resulting cellular phenotypes, such as increased cytoplasmic accumulation of undigested material. This provides a powerful platform for screening potential therapeutic compounds or assessing gene therapy efficacy.

In the realm of scientific research and clinical applications, these knockout cell lines are invaluable. They can serve as in vitro models for studying the cellular mechanisms of diseases like Chédiak-Higashi syndrome, which is caused by mutations in the LYST gene. Furthermore, they can assist in drug discovery efforts aimed at restoring lysosomal function or alleviating symptoms associated with lysosomal storage disorders.

The advantages of using LYST Gene Knockout Cell Lines over traditional models include their reliability, specificity, and the ability to produce reproducible results that are crucial for hypothesis-driven research. Compared to alternative cell lines, these genetically modified cells offer a direct approach to examining the effects of LYST gene ablation, yielding insights that might be obscure in less targeted models.

In conclusion, the LYST Gene Knockout Cell Lines provide significant value to researchers and clinicians by enabling them to explore novel therapeutic avenues for diseases linked to lysosomal dysfunction. With years of expertise in advanced cell line engineering and a commitment to quality, we ensure that our products meet the highest standards of scientific integrity and applicability, streamlining your research efforts in the field of cellular biology.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.